ABK-CDK4

N/A

Report date: 2026/05/18 20:02:07
NME

Base Information

Drug NameABK-CDK4
Drug Alias NameABK-CDK4ABKCDK4
ClassificationSmall molecules
Mechanisms of ActionCyclin-dependent kinase 4 inhibitors
TargetsCyclin-dependent kinase 4
Therapy Area/IndicationsBrain metastases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesABbisko Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesABbisko Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsBrain metastases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A